Target intelligence / Profile preview

Peroxisomal biogenesis factor 13 (PEX13)

Target
PEX13
Molecular classification
peroxisomal membrane protein, peroxin
01

Overview

Peroxisomal biogenesis factor 13 (PEX13) is an integral peroxisomal membrane protein and a core component of the peroxisomal protein import machinery[3][2]. It interacts with the type 1 peroxisomal targeting signal receptor (PEX5) via an SH3 domain and forms the PEX13–PEX14 docking complex, which is essential for the import of peroxisomal matrix proteins[3]. PEX13 is also required for selective autophagy processes, such as mitophagy and virophagy, independently of general autophagy pathways[2][5]. Mutations in PEX13 cause peroxisome biogenesis disorders of the Zellweger syndrome spectrum, characterized by impaired peroxisomal protein import, leading to multi-organ, especially neurological, abnormalities and neonatal lethality[2][3][1][5]. The role of PEX13 is specific to peroxisome assembly and import, and it is not currently considered a direct therapeutic target or receptor in drug development[3][2][5].

Other names
Peroxisomal membrane protein PEX13Peroxin-13PBD11APBD11BZWSNALD
02

Biological functions

Peroxisome biogenesisPeroxisomal matrix protein importSelective autophagy (including mitophagy and virophagy)
03

Disease associations

Peroxisome biogenesis disordersZellweger syndrome spectrumneonatal adrenoleukodystrophyZellweger syndrome
04

Safety considerations

Genetic deficiency leads to peroxisome biogenesis disorders with severe neurological, hepatic, and renal manifestations
05

Biomarkers

Very long-chain fatty acid levelsPlasmalogen levels

Beyond the preview

Go deeper on Peroxisomal biogenesis factor 13 (PEX13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Peroxisomal biogenesis factor 13 (PEX13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call